Page 237 - Clinical Manual of Small Animal Endosurgery
P. 237

Female Reproductive Tract  225

























                                  Fig. 7.18  TCC in the trigone showing a classic fimbriated appearance.

                                  surface and forming a solid mass within the wall of the bladder may be
                                  seen. This second type may carry a worse prognosis as in the author’s
                                  experience they are more rapidly growing and refractory to treatment.
                                    Invariably cases are not presented until they are quite advanced and
                                  resulting in clinical signs of urinary obstruction: pollakiuria, stranguria,
                                  haematuria  and  tenesmus.  Treatment  with  certain  non-steroidal  anti-
                                  inflammatory  agents,  especially  piroxicam  (0.3 mg/kg  by  mouth  every
                                  24 h), is useful and may be combined with other chemotherapeutic agents
                                  such as mitoxantrone (5 mg/m2 intravenous every 3 weeks for four treat-
                                  ments) (Upton et al., 2006). However these treatments are most effective
                                  if  introduced  before  clinical  signs  of  urethral  blockage  occur.  Laser
                                  debulking of the tumour tissue can significantly improve morbidity and
                                  relieve clinical signs completely.
                                    A diode laser is passed through the instrument channel of the cysto-
                                  scope and used to ablate around 90–95% of the tumour tissue. Neoplas-
                                  tic tissue which is not adjacent to the normal margins of the bladder and
                                  urethral wall may be ablated in non-contact mode using 10–15 W. This
                                  devitalises tissue, which will subsequently slough away. Near the margins
                                  of the normal bladder wall and urethral wall contact mode is used at
                                  around 9–10 W to give more precise control and a cutting effect. This
                                  allows  very  careful  resection  of  tumour  tissues  with  minimal  risk  of
                                  perforation (Fig. 7.19). If haemorrhage obscures the view the bladder
                                  may be drained and filled with carbon dioxide or room air. The former
                                  is safer as the risk of air embolism is reduced. Laser ablation carried out
                                  in air carries additional risk of perforation since tissue heating and col-
                                  lateral spread are greater without the heat-sink effect of fluid. Great care
                                  must be taken not to devitalise deep tissues. Ablation must be done care-
                                  fully  and  slowly  and  can  be  a  time-consuming  procedure.  Extensive
                                  neoplasia may take 2–3 h or longer to ablate.
   232   233   234   235   236   237   238   239   240   241   242